Your Mounjaro price guide · October 2026
Are GLP-1 Pills as Effective as Injections? (October 2026)
GLP-1 pills can produce meaningful weight loss, but no trial has compared Mounjaro directly with either licensed GLP-1 tablet, so nobody can honestly say they are exactly as effective as injections. Each tablet has its own trial result, and the practical routines differ.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Pills versus injections, honestly
Two GLP-1 weight-loss tablets are now licensed in the UK, so the pill-or-injection question is real. The honest answer depends on which pill, which injection, and what you can stick to.
- Price includes prescriber assessment and standard delivery — no consultation fees
- Orders approved by 3pm for next-day tracked delivery
- GPhC-registered pharmacy 9012878
- Needles and sharps disposal included
Compare UK Mounjaro Prices
Prices checked 12 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
No trial has compared Mounjaro directly with Wegovy tablets or Foundayo, so a like-for-like effectiveness ranking does not exist.
-
Wegovy tablets and Foundayo each have their own trial results, in different people, over different durations and at different doses.
-
The practical differences matter: Wegovy tablets need a strict empty-stomach routine, Foundayo has no food or water rules, Mounjaro is one injection a week.
-
SURMOUNT-5 is the trial that compared tirzepatide directly with injected semaglutide.
-
A GPhC-registered prescriber can check which option suits your health, other medicines and routine.
In this guide
01 · The core answer
Are GLP-1 pills as effective as injections?
GLP-1 pills are licensed treatments, but no trial lets you declare them equal to injections. Mounjaro is a once-weekly injection; Wegovy tablets and Foundayo are once-daily tablets. No trial has compared Mounjaro directly with either tablet, so results from separate trials, with different people, durations and doses, should not be set against each other as if they were head to head.20
The one direct comparison that does exist is SURMOUNT-5, which compared tirzepatide with injected semaglutide. It does not involve any tablet.15
02 · Evidence
What the separate trials show
Each tablet has its own trial result. In the OASIS 4 trial, adults taking semaglutide 25mg tablets for 64 weeks lost on average 13.6% of their body weight, compared with 2.2% on placebo.22 In the ATTAIN-1 trial of 3,127 adults without type 2 diabetes, people taking the highest dose of orforglipron for 72 weeks lost on average 12.4% of their body weight, compared with 0.9% on placebo; the two lower doses gave 7.8% and 9.3%.23
These are averages, and individual results vary. They are also not interchangeable with each other: the trials ran for different lengths of time in different groups of people. Read each number as an answer to "what happened on this tablet in this trial", never as a league table.
03 · Side by side
Mounjaro injection, Wegovy tablets and Foundayo compared
| Factor | Mounjaro injection | Wegovy tablets | Foundayo |
|---|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide (oral) | Orforglipron |
| How often | Once a week, under the skin | One tablet once a day | One tablet once a day |
| Food and water rules | None; any time of day, with or without food | Strict empty-stomach routine every morning | None; any time of day, with or without food |
| Direct trial against another GLP-1 | SURMOUNT-5 versus injected semaglutide | Own trial (OASIS 4) only | Own trial (ATTAIN-1) only |
| Oral contraceptive note | Can reduce absorption of oral contraceptives: switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase | Ask your prescriber | May make oral contraceptive pills less effective: switch to a non-oral method or add a barrier method for 30 days after starting and after each dose increase |
| Price | See the live Mounjaro pen page | See current Wegovy tablet prices | See current Foundayo prices |
04 · Your decision
What should you do next?
Start with what you will realistically keep doing, then ask a prescriber which licensed option fits. A pill you take reliably and tolerate may serve you better than an injection you dread, and the reverse can be true. A prescriber will check which option is suitable for your health, your other medicines and your routine.20
If you are weighing up the options, our weight loss clinic explains how a free consultation works, and the Mounjaro pen page shows live prices for the injection and current availability, which is in stock across the doses.
05 · Wegovy tablets
Wegovy tablets: routine and results
Wegovy tablets contain semaglutide, the same active ingredient as the Wegovy injection, taken as one tablet once a day. They are licensed for weight management in adults with a BMI of 30 or above, or 27 to under 30 with at least one weight-related condition, alongside a reduced-calorie diet and more physical activity.20
The routine is the main thing to weigh up. The tablet must be taken on an empty stomach after fasting for at least 8 hours, swallowed whole with a sip of water (up to half a glass, about 120ml), and you then wait at least 30 minutes before eating, drinking or taking other tablets.20 That suits some mornings and not others, so be honest about your day before choosing it.
Treatment starts at 1.5mg once daily and steps up to 4mg, 9mg and then the 25mg maintenance dose, with at least one month at each dose; the dose can stay at an earlier step if needed.20 If a dose is missed, skip it and take the next tablet the following day.
In OASIS 4, 76.3% lost at least 5% of their body weight (vs 30.5% on placebo) and 59.8% lost at least 10% (vs 14.1%).22 The most common side effects are digestive: nausea, vomiting, diarrhoea, constipation, indigestion and stomach pain, along with headache and tiredness; gallstones and hair loss are listed as common.22
06 · Foundayo (orforglipron)
Foundayo: a tablet without the food rules
Foundayo contains orforglipron, a once-daily GLP-1 tablet made by Eli Lilly, the maker of Mounjaro. Unlike Wegovy tablets it can be taken at any time of day, with or without food and without water restrictions; the tablet is swallowed whole.21 It is licensed for adults with a BMI of 30 or above, or 27 to under 30 with at least one weight-related condition, alongside a reduced-calorie diet and more physical activity.
Treatment starts at 0.8mg once daily, then steps up to 2.5mg and 5.5mg, and then to 9mg, 14.5mg or 17.2mg depending on response and tolerability, with at least 30 days at each dose; 17.2mg once daily is the maximum.21 If a dose is missed, take it as soon as possible, but never more than one tablet a day.
One detail is easy to miss. Foundayo may make oral contraceptive pills less effective: switch to a non-oral method or add a barrier method for 30 days after starting and for 30 days after each dose increase.21
The ATTAIN-1 trial used capsules, and the UK 17.2mg tablet corresponds to the highest trial dose, so the tablet and capsule doses are not comparable milligram for milligram.23 The most common side effects are digestive: nausea, constipation, diarrhoea, vomiting, indigestion and stomach pain. In the trial, 10.3% of people on the highest dose stopped because of side effects, compared with 2.7% on placebo.23 Our page on whether oral GLP-1 is as effective as injections goes deeper on the oral route.
07 · The injection route
The injection route: what you get with Mounjaro
Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes, and comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.1
Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1 That dual action distinguishes it from single-action GLP-1 medicines such as semaglutide.
Day to day, the routine is light. Mounjaro is injected under the skin once a week, on the same day each week, at any time of day, with or without food.1 There is no "best" time of day: it works the same morning or evening, and what matters is the same day each week. Each KwikPen contains four weekly doses. For people who dislike daily tablets or cannot manage a fasting routine, that is a real advantage. For people who dislike needles, it is not.
For the one head-to-head comparison that exists between tirzepatide and injected semaglutide, see SURMOUNT-5.15 It tells you about two injections, not about tablets.
08 · Switching and pace
Switching between injection and tablet
Moving from injection to tablet is possible for some people, with a defined route. People on the 2.4mg weekly Wegovy injection can move to the 25mg tablet, starting one week after their last injection.20 The prescriber decides when to switch between Mounjaro and either tablet and which dose to start on. Ask your prescriber, who will take your dose, tolerance and other medicines into account.
The pace of results is similar in spirit whichever route you choose: gradual by design. Weight loss on Mounjaro is gradual, the first weeks on 2.5mg are an adjustment phase and losses are usually modest, and most measurable progress builds from 5mg onward, month by month.1 Think in months, not days, and judge progress by trend, not individual weigh-ins.
Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.1 A tablet that you take inconsistently will not outperform an injection you take reliably, and the reverse is equally true.
09 · Why summaries mislead
Why quick summaries can mislead
Many quick answers say pills are "nearly as good" as injections and quote a pair of percentage ranges. Treat those with caution. Ranges blend different drugs, different trials, different durations and different populations, and the comparison they imply has not been tested head to head for Mounjaro and the tablets.20
The honest way to compare is to ask three questions. What did this specific product achieve in its own trial? How long did the trial run? And what does the routine demand of me every day or week? Averages also hide the spread: some people lose far more than the average, some far less, and trial averages do not predict your own result.
It is also worth separating tablets from "natural" alternatives. There is no tablet form of Mounjaro, because tirzepatide is injection-only in the UK. Orlistat (tablet) blocks some dietary fat absorption and produces smaller average losses. Supplements such as berberine are not medicines, are not regulated for this use and have no comparable trial evidence.20 Our related guide on whether weight loss pills are as effective as injections covers that wider group.
10 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1
11 · Choosing and NHS access
Choosing a route, and NHS access
Choose on suitability and routine first. Wegovy tablets need a strict empty-stomach routine every morning, Foundayo has no food or water rules, and Mounjaro needs one injection a week.20 Eligibility also differs: the tablets, like Mounjaro, are licensed from a BMI of 30, or from 27 with a weight-related condition, while NHS criteria for Mounjaro are narrower.
On the NHS, Mounjaro is available but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).46 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.
Whichever route you take, all of these are prescription-only medicines. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Existing customers also get ongoing monthly reviews. You can compare more in our guide on whether the GLP-1 pill is as effective as the shot, and in how GLP-1 pills work compared with injections.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamIs a GLP-1 injection or pill better?
Is GLP-1 effective in pill form?
Are oral GLP-1 as effective as injections?
Which GLP-1 is best for weight loss and is faster?
What is the absolute best weight loss pill?
What is known as the "poor man's Ozempic"?
How can I mimic Ozempic naturally?
What is a cheaper alternative to Ozempic?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 10 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med 2025
- Wegovy tablets (oral semaglutide) — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Foundayo (orforglipron) film-coated tablets — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4). N Engl J Med 2025
- Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, for Obesity Treatment (ATTAIN-1). N Engl J Med 2025
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


